DeepCyte

DeepCyte is an AI-driven biotechnology company specializing in high-throughput single-cell analysis and drug discovery. The company integrates microfluidics, deep learning, and advanced imaging to characterize cellular phenotypes at scale, enabling the identification of novel therapeutic targets and the optimization of drug candidates. DeepCyte's platform is designed to accelerate the development of precision medicines, particularly in oncology and immunology, by providing high-resolution insights into cellular behavior and response. By leveraging computer vision and automated workflows, the company aims to transform how complex biological data is translated into therapeutic breakthroughs.